Evommune Inc (EVMN)

Currency in USD
13.51
+0.26(+1.96%)
Closed·
13.50-0.01(-0.07%)
·
Unusual trading volume
EVMN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.2514.11
52 wk Range
12.0733.20
Key Statistics
Prev. Close
13.51
Open
13.86
Day's Range
13.25-14.11
52 wk Range
12.07-33.2
Volume
1.44M
Average Volume (3m)
709.47K
1-Year Change
-
Book Value / Share
8.46
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EVMN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
31.14
Upside
+130.52%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Evommune Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

8 Buy
2 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 31.14
(+130.52% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Morgan Stanley
Buy26.00+92.45%55.00MaintainJun 30, 2026
H.C. Wainwright
Hold---DowngradeJun 30, 2026
Clear Street
Buy28.00+107.25%53.00MaintainJun 29, 2026
Raymond James
Buy32.00+136.86%52.00DowngradeJun 29, 2026
William Blair
Hold---DowngradeJun 29, 2026

Earnings

Latest Release
May 08, 2026
EPS / Forecast
-0,64 / -0,76
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

EVMN Income Statement

Compare EVMN to Peers and Sector

Metrics to compare
EVMN
Peers
Sector
Relationship
P/E Ratio
−6.4x−1.8x−0.4x
PEG Ratio
−0.070.550.00
Price/Book
1.6x2.9x2.6x
Price / LTM Sales
48.7x17.3x3.0x
Upside (Analyst Target)
107.3%237.0%51.9%
Fair Value Upside
Unlock9.3%9.1%Unlock

Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is headquartered in Palo Alto, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5,94M16,49%78,71M
Other Institutional Investors
45,16M83,51%598,40M
Public Companies & Retail Investors
0,000,00%0,00
Total
51,1M100,00%677,11M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Eqt Fund Management S.à R.L.13,69%4 929 63365 318
LSP 7 Cooperative UA13,69%4 929 63365 318

FAQ

What Is the Evommune (EVMN) Stock Price Today?

The Evommune stock price today is 13,51 USD.

What Stock Exchange Does Evommune Trade On?

Evommune is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Evommune?

The stock symbol for Evommune is "EVMN."

What Is the Evommune Market Cap?

As of today, Evommune market cap is 486,61M USD.

What Is Evommune's Earnings Per Share (TTM)?

The Evommune EPS (TTM) is -5,36.

When Is the Next Evommune Earnings Date?

Evommune will release its next earnings report on Sep 02, 2026.

From a Technical Analysis Perspective, Is EVMN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Evommune Stock Split?

Evommune has split 0 times.

How Many Employees Does Evommune Have?

Evommune has 48 employees.

What is the current trading status of Evommune (EVMN)?

As of Jul 10, 2026, Evommune (EVMN) is trading at a price of 13,51 USD, with a previous close of 13,51 USD. The stock has fluctuated within a day range of 13,25 USD to 14,11 USD, while its 52-week range spans from 12,07 USD to 33,20 USD.

What Is Evommune (EVMN) Price Target According to Analysts?

The average 12-month price target for Evommune is 31,14 USD, with a high estimate of 54 USD and a low estimate of 22 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +130,52% Upside potential.

What Is the EVMN Premarket Price?

EVMN's last pre-market stock price is 13,50 USD. The pre-market share volume is 1 160,00, and the stock has decreased by -0,01, or -0,07%.

What Is the EVMN After Hours Price?

EVMN's last after hours stock price is 13,90 USD, the stock has decreased by 0,39, or 2,90%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.